UCP1 and obesity disorder: Activation of thermogenic pathways, particularly via cAMP-mediated signaling that upregulates UCP1, PRD1-BF1-RIZ1 homologous domain containing 16 (PRDM16), and PGC1α, represents a promising therapeutic approach for obesity [5,8,9].